News – Page 820 – Endpoints News

Biogen's last-ditch pitch for an injunction to protect Tecfidera is denied, paving way for Mylan generic

5 years ago

Novartis turns to Sangamo with a $795M-plus deal aimed at using zinc finger tech for the neuro pipeline

5 years ago

Bristol Myers Squibb and bluebird bio return to FDA; Takeda gets a breakthrough nod

5 years ago

F-star's Eliot Forster maps a shortcut to Wall Street, bagging more cash to fuel oncology pipeline work

5 years ago

Lexicon bids farewell to top seller Xermelo in reorganization toward R&D pipeline

5 years ago

The lead drug in Alexion’s $930M buyout deal last fall just flopped — adding injury to analysts’ M&A insults

5 years ago

Covid-19 afflicts Eli Lilly’s share price and a KRAS drug gets tossed, but Jardiance win salves the wound as an ...

5 years ago

Covid-19 roundup: J&J gives deepest look yet at vaccine; AstraZeneca shies away from discussing vaccine commercial ...

5 years ago

Adding $445M, Tony Coles and his big Pfizer neuro spinout hitch a ride to Wall Street on Perceptive’s SPAC

5 years ago

AbbVie preps a challenge to a rival migraine drug from Biohaven, spelling out an upbeat set of PhIII data

5 years ago

Genentech slashes nearly 500 jobs in strategic shift to 'local healthcare ecosystems.' Clinical specialists make up ...

5 years ago

Moderna, Pfizer begin to give glimpse of Covid-19 vaccine pricing — and profits

5 years ago

Roche/Genentech doubles down on tau, fronting $120M cash to ally on a 2-pronged strategy to fight Alzheimer’s

5 years ago

Codiak gets a competitor, as Mantra Bio leaves stealth and enters growing exosome space

5 years ago

GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap

5 years ago

Sanofi prunes its pipeline, taking the ax to a lineup of drug, vaccine programs

5 years ago

'Exquisite control': Flagship pulls off $85M rally around Omega Therapeutics' clinical push for epigenetic ...

5 years ago

Three years after leaving Biogen, Alpna Seth takes the spotlight with $73M for her neuro startup

5 years ago

Covid-19 roundup: Moderna removed signs around its manufacturing plant — is it a target for hackers?

5 years ago

Inhibrx takes a second shot at an IPO — this time bumping the goal to $100M-plus

5 years ago

Test results in hand, Thrive raises $257M to push liquid biopsy toward approval

5 years ago

Trump, Big Pharma trade barbs over drug pricing EOs; BARDA gives Regeneron $350M for Ebola drugs

5 years ago

Roche declares a PhIII failure for Covid-19 as the IL-6 repurposing theory bites the dust

5 years ago

Amgen dumps early-stage CD38xCD3 bispecific as 3 programs are sidelined by trial setbacks

5 years ago

First page Previous page 817 818 819820821 822 823 Next page Last page